C07K 16/1278
Bacillus
Official title: Bacillus (G)
C07K16/1278 (Bacillus) appears on 134 US grants and 184 published applications in this corpus.
Search patents in C07K- Granted patents
- 134
- Published applications
- 184
- Assignees
- 102
- Inventors
- 329
- Latest grant
- 3 Mar 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1990 | 1 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 2 | 0 |
| 1994 | 1 | 0 |
| 1995 | 0 | 0 |
| 1996 | 1 | 0 |
| 1997 | 0 | 0 |
| 1998 | 3 | 0 |
| 1999 | 0 | 0 |
| 2000 | 1 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 1 |
| 2003 | 1 | 5 |
| 2004 | 2 | 7 |
| 2005 | 2 | 6 |
| 2006 | 1 | 8 |
| 2007 | 3 | 6 |
| 2008 | 7 | 7 |
| 2009 | 2 | 8 |
| 2010 | 6 | 14 |
| 2011 | 4 | 14 |
| 2012 | 8 | 14 |
| 2013 | 13 | 11 |
| 2014 | 7 | 10 |
| 2015 | 8 | 11 |
| 2016 | 14 | 15 |
| 2017 | 12 | 11 |
| 2018 | 7 | 5 |
| 2019 | 9 | 7 |
| 2020 | 6 | 5 |
| 2021 | 1 | 5 |
| 2022 | 2 | 0 |
| 2023 | 2 | 3 |
| 2024 | 5 | 5 |
| 2025 | 1 | 3 |
| 2026 | 2 | 3 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Ostrich antibody for bacterial infectious diseases3 Mar 2026US 12,564,624 B2Ostrich Pharma KK
- BCG car constructs and methods of their manufacture and use13 Jan 2026US 12,522,651 B2Versiti Blood Research Institute Foundation, Inc.
- Hybridoma cell line secreting an ActA monoclonal antibody and use thereof11 Nov 2025US 12,467,922 B2Yangzhou University
- Methods and means for the production of Ig-like molecules22 Oct 2024US 12,123,043 B2Merus N.V.
- VHH based binding antibodies for anthrax and botulinum toxins and methods of making and using therefor20 Aug 2024US 12,065,486 B2Trustees of Tufts College
- Methods and means for the production of ig-like molecules8 Oct 2026US 2026/0308655 A1Merus N.V.
- Methods and means for the production of ig-like molecules20 Aug 2026US 2026/0242840 A1Merus N.V.
- Vaccines and Antibodies for the Treatment and Prevention of Neurodegenerative Disorders and Inflammation Related Health Conditions16 Apr 2026US 2026/0102478 A1Longhorn Vaccines and Diagnostics, LLC
- A biomarker and compositions to increase the therapeutic index of neoadjuvant immunotherapy in muscle-invasive urothelial carcinoma21 Aug 2025US 2025/0264457 A1
- Hybridoma cell line secreting an ActA monoclonal antibody and use thereof3 Apr 2025US 2025/0110125 A1Yangzhou University
Most cited
By later US patents
- Human monoclonal antibodies against Bacillus anthracis protective antigen74US 7,456,264 B2Medarex, Inc. · 2008
- Transformation vectors allowing expression of Bacillus thuringiensis endotoxins in plants73US 5,254,799 APlant Genetic Systems, N.V. · 1993
- Methods and means for the production of Ig-like molecules67US 9,248,182 B2Merus N.V. · 2016
- Methods and means for the production of Ig-like molecules66US 9,248,181 B2Merus N.V. · 2016
- Assays for detection of Bacillus anthracis49US 6,828,110 B2Biosite, Inc. · 2004